Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

First Rand Foundation contributes funding towards students with disabilities
2017-01-02

 Description: First Rand Foundation Tags: First Rand Foundation

Photo: iStock

Bursary funding for eight students with disabilities at the University of the Free State was recently approved by the First Rand Foundation. The grant of R2 497 440 will be paid over three years: R800 000 (2016/17), R824 000 (2017/18), and R873 440 (2018/19).

This grant from the First Rand Tertiary Education Fund is a result of the negotiations between the UFS Office for Institutional Advancement and the First Rand Foundation (FRF).

Qualifying students with disabilities will be encouraged to apply for bursaries according to criteria and requirements set by the First Rand Foundation. The selection process will be handled by a panel from the UFS. The Centre for Universal Access and Disability Support (CUADS) at the UFS will be instrumental in the process of identifying students with disabilities who meet the criteria and requirements for funding.

CUADS already have a system in place to support students with disabilities in their studies and during exams. Students also have access to specialised exam and test venues for alternative test and exam procedures, as well as computer facilities.

Specialised support services include an amanuensis (scribe) service during tests and exams, accommodating extra time, individual tutor sessions provided in collaboration with the Centre for Teaching and Learning, South African Sign Language interpreter coordination, provision of accessible study material, and individual disability support.

 

“The centre aims to ensure that the university increasingly becomes a universally accessible environment that is welcoming and accepting to people with diverse abilities.”

According to Martie Miranda, Head of CUADS, the centre aims to ensure that the university increasingly becomes a universally accessible environment that is welcoming and accepting to people with diverse abilities. “Therefore disability awareness training and advocacy within the UFS, and specifically among staff members, is one of our priorities,” she said.

According to Thandeka Rantsi from the FRF, the company will furthermore support students in CUADS with regards to the needs ensuing from the #feesmustfall protests. “Exactly R34 000 was approved by the FRF for 14 students towards residence and meal expenses, as well as scribe and reader assistance during additional assessments,” she said.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept